← brief for 2026-09-23 · Slowing decline
Renal outcomes in people with type 2 diabetes with and without albuminuria treated with SGLT-2 inhibitors and GLP-1 receptor agonists: target trial emulation.
Key takeaways
This large study used data from many health systems to compare two diabetes drugs. It looked at people with type 2 diabetes and kidney function above a certain level. The study found that these drugs help protect the kidneys. This is strong evidence because it analyzed a very large group of patients.
Who did this work
Turchin A · Petito LC · Hegermiller E · Chelliah I · Carnahan RM · DeVries A · Goel S · Lansang MC · McDonnell ME · Nair V · Priest E · Willey VJ
Source
Article · PubMed, the drug frontier · 2026 Sep 16
https://pubmed.ncbi.nlm.nih.gov/42778221/